| 000 | 01591 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515210019.0 | ||
| 264 | 0 | _c20100420 | |
| 008 | 201004s 0 0 eng d | ||
| 022 | _a2078-2101 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZekri, J M | |
| 245 | 0 | 0 |
_aA matched case-control study of Triple negative vs. HER-2 positive (irrespective of hormonal status) breast cancer: two subtypes with high risk features and poor outcome. _h[electronic resource] |
| 260 |
_bThe Gulf journal of oncology _cJan 2010 |
||
| 300 |
_a14-20 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 |
_aBreast Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoenzyme Techniques |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNeoplasms, Hormone-Dependent _xmetabolism |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Estrogen _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Progesterone _xmetabolism |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aIbrahim, E | |
| 700 | 1 | _aAl-Gahmi, A M | |
| 700 | 1 | _aZeeneldin, A A | |
| 700 | 1 | _aElkhodary, T R | |
| 700 | 1 | _aGaballa, H E | |
| 700 | 1 | _aFawzy, E E | |
| 700 | 1 | _aElsayed, M E | |
| 700 | 1 | _aBahadur, Y | |
| 700 | 1 | _aAwadalla, S | |
| 700 | 1 | _aAlzahran, M S | |
| 700 | 1 | _aBen Sadiq, B | |
| 773 | 0 |
_tThe Gulf journal of oncology _gno. 7 _gp. 14-20 |
|
| 999 |
_c19533641 _d19533641 |
||